Silencing a liver gene may prevent brain damage from rare metabolic disease

Medical Xpress - latest medical and health news stories ·
Health & Medicine United Kingdom

What if the path to treating a rare condition that harms the brain goes through the liver? A new study by Duke University School of Medicine researchers is the first to show preclinical success of a liver-targeting treatment of glutaric aciduria type I (GA1).

Read original article on Medical Xpress - latest medical and health news stories →